Skip to main content
Rami Khoriaty, MD, Oncology, Ann Arbor, MI

RamiNaimKhoriatyMD

Oncology Ann Arbor, MI

Hematologic Oncology

Physician

Dr. Khoriaty is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Khoriaty's full profile

Already have an account?

  • Office

    1500 E Medical Center Dr
    B1 Floor Cancer Recp B
    Ann Arbor, MI 48109
    Phone+1 734-936-6000

Education & Training

  • University of Michigan
    University of MichiganFellowship, Hematology and Medical Oncology, 2009 - 2012
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 2006 - 2009
  • American University of Beirut Faculty of Medicine
    American University of Beirut Faculty of MedicineClass of 2005

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2009 - 2025
  • OH State Medical License
    OH State Medical License 2006 - 2009
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Journal Articles

  • Functions of the COPII Gene Paralogs SEC23A and SEC23B Are Interchangeable in Vivo  
    Rami Khoriaty, Lesley Everett, Jordan A Shavit, Angela C Weyand, David Ginsburg, Proceedings of the National Academy of Sciences

Abstracts/Posters

  • Functional Overlap between the SEC23 Paralogs Suggests a Novel Treatment Paradigm for Congenital Dyserythropoietic Anemia Type II
    Rami Khoriaty, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Key Pathway for Activated T-cells Might Be Targeted to Fight GVHD
    Key Pathway for Activated T-cells Might Be Targeted to Fight GVHDJanuary 21st, 2021

Professional Memberships